DOI QR코드

DOI QR Code

Unusual Intronic Variant in GSTP1 in Head and Neck Cancer in Pakistan

  • Masood, Nosheen (Department of Biosciences, COMSATS Institute of Information and Technology) ;
  • Malik, Faraz Arshad (Department of Biosciences, COMSATS Institute of Information and Technology) ;
  • Kayani, Mahmood Akhtar (Department of Biosciences, COMSATS Institute of Information and Technology)
  • Published : 2012.04.30

Abstract

In the present case control study mRNA expression of the GSTP1 gene, encoding a phase II enzyme that detoxifies via glutathione conjugation, was investigated using semiquantitative PCR followed by SSCP for 49 confirmed head and neck (HN) cancer and 49 control samples. It was found that GSTP1 was upregulated in significantly higher number of cancers (OR 4.2, 95% CI 1.2-15.3). Grade wise correlation was also observed with more up regulation in patients with more advanced grades of HN carcinomas. We also found that 5 patients showed variation in mRNA with a larger product size than expected. Sequencing revealed insertion of an intronic segment between the $6^{th}$ and $7^{th}$ exon of the GSTP1 gene. Germline screening was performed showing mobility shifts which suggested mutation at the DNA level resulting in intronic portion retention. This study is of prime importance for drug design and treatment selection to overcome increased resistance of HN cancers to drugs due to alteration in the GSTP1 gene.

Keywords

References

  1. Aliya S, Reddanna P, Thyagaraju K (2003) Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer? Mol Cell Biochem, 253, 319-27. https://doi.org/10.1023/A:1026036521852
  2. Anita J, Wai MY, Nam GT, et al (2002) Glutathione S transferase pi expression in nasopharyngeal cancer. Arch Otolaryngol Head Neck Surg, 128, 1396-9. https://doi.org/10.1001/archotol.128.12.1396
  3. Arun BK, Granville LA, Yin G, et al (2010) Glutathione-stransferase- pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Invest, 28, 554-9. https://doi.org/10.3109/07357900903286925
  4. Conklin DJ, Haberzettl P, Prough RA, et al (2009) Glutathione- S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am J Physiol Heart Circ Physiol, 296, 1586-97. https://doi.org/10.1152/ajpheart.00867.2008
  5. De Bruin WC, Wagenmans MJ, Peters WH (2000) Expression of glutathione S-transferase alpha, P1-1 and T1-1 in the human gastrointestinal tract. Jpn J Cancer Res, 91, 310-6. https://doi.org/10.1111/j.1349-7006.2000.tb00946.x
  6. Faheem A (2007) Cancer registration in Pakistan: contemporary state of affairs. Asia Pac J cancer prev, 8, 452-6.
  7. Fusako N, Eriko K, Hiro-omi T (2004) Oxidative stress induces GSTP1 and CYP3A4 expression in the human erythroleukemia cell lines, K562. Biol Pharm Bull, 27, 492-5. https://doi.org/10.1248/bpb.27.492
  8. Gajewska B, Usarek E, Kazmierczak B, et al (2007) Expression of glutathione S-transferase isoenzymes in tongue and floor of mouth squamous cell carcinomas. Pol Merkur Lekarski, 23, 196-9.
  9. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol, 45, 51-88. https://doi.org/10.1146/annurev.pharmtox.45.120403.095857
  10. Hayes JD, Pulford DJ (1995) The glutathione S transferase supergene family. Crit Rev, 30, 445-600. https://doi.org/10.3109/10409239509083491
  11. Holley SL, Fryer AA, Haycock JW et al (2007) Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis, 28, 2268-73. https://doi.org/10.1093/carcin/bgm135
  12. Ioanna AD, Demetrios AA, Demetrios AS (2001) Genetic polymorphisms and transcriptional pattern analysis od CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. Int J mol med, 8, 79-87.
  13. Isabel S, Klaus J, Philipp S, et al (2010) Gene promoter methylation and its potential relevance in early prostate cancer diagnosis. Pathobiol, 77, 260-6. https://doi.org/10.1159/000318017
  14. Johnson NW (1991). A global view of the epidemiology of oral cancer, in risk markers for oral diseases. Cambridge: University Press:3-27.
  15. Kim SH, Kwon HC, Oh SY, et al (2009) Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Am J Clin Oncol, 32, 38-43. https://doi.org/10.1097/COC.0b013e31817be58e
  16. Lo HW, Ali-Osman F (1997) Genomic cloning of hGSTP1*C, an allelic human $\pi$ class glutathione S-transferase gene variant and functional characterization of its retinoic acid response elements. J Biol Chem, 272, 32743-9. https://doi.org/10.1074/jbc.272.52.32743
  17. Lo HW, Ali-Osman F (2002) Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation. J Cell Biochem, 87, 103-16. https://doi.org/10.1002/jcb.10275
  18. Matthias C, Bockmuhl U, Jahnke V, et al (1998) The glutathione-S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics, 8, 1-6. https://doi.org/10.1097/00008571-199802000-00001
  19. Moffat GJ, McLaren AW, Wolf CR (1996). Sp1-mediated transcriptional activation of the human $\pi$ class glutathione S-transferase promoter. J Biol Chem, 271, 1054-60. https://doi.org/10.1074/jbc.271.2.1054
  20. Moyer AM, Salavaggione OE, Wu TY, et al (2008). Glutathione S transferase p1: gene sequence variation and functional genomic studies. Cancer res, 68, 4791. https://doi.org/10.1158/0008-5472.CAN-07-6724
  21. Nelson WG, De Marzo AM, Deweese TL, et al (2001). Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann N Y Acad Sci, 952, 135-44.
  22. Nosheen M, Kayani MA (2011) Mutational analysis of xenobiotic metabolizing genes (CYP1A1 and GSTP1) in sporadic head and neck cancer patients. Genet mol boil, 34, 533-8. https://doi.org/10.1590/S1415-47572011005000034
  23. Nosheen M, Malik FA, Kayani MA (2011) Expression of xenobiotic metabolizing genes in head and neck cancer tissues. APJCP, ?, 377-82.
  24. Okino ST, Pookot D, Majid S, et al (2007). Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog, 46, 839-46. https://doi.org/10.1002/mc.20313
  25. Parkin DM, Whelan SL, Ferlay J, et al (2002) Cancer incidence in five continents, vol. VIII. IARC scientific publications No. 155 Lyon: IARC.
  26. Ritchie KJ, Walsh S, Sansom OJ, et al (2009). Markedly enhanced colon tumorigenesis in ApcMin mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci, 106, 20859-64. https://doi.org/10.1073/pnas.0911351106
  27. Scharmach E, Hessel S, Niemann B, et al (2009). Glutathione S-transferase expression and isoenzyme composition during cell differentiation of Caco-2 cells. Toxicology, 265, 122-6. https://doi.org/10.1016/j.tox.2009.09.017
  28. Usarek E, Kloniecki M, Osuch-Wojcikiewicz E et al (2004) Expression of glutathione-S-transferase isoenzymes in larynx cancer. Otolaryngol Pol, 58, 895-89.
  29. Wang T, Arifoglu P, Ronai Z, et al (2001). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C-terminus. J Biol Chem, 276, 20999-1003. https://doi.org/10.1074/jbc.M101355200
  30. Xia C, Hu J, Ketterer B et al (1996) The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J, 313, 155-61
  31. Yang RX, Pfeiffer RM, Goldstein AM (2006) Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the ovoid basal cell carcinoma syndrome. J Med Genet, 43, 16.
  32. Yu PF, Guo JM, Xu Q et al (2010) Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis. Zhonghua Wei Chang Wai Ke Za Zhi, 13, 289-93.
  33. Zhong LP, Zhao SF, Chen GF, et al (2006). Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Arch Oral Biol, 1, 1112-9.

Cited by

  1. Genetic variations and head and neck cancer risks vol.41, pp.4, 2014, https://doi.org/10.1007/s11033-014-3125-6